CDC Funds State, Local HIV Prevention Efforts

(MedPage Today) — The Centers for Disease Control and Prevention has announced grants of $339 million to state and local health departments for HIV prevention activities in 2012.

CDC: 22.6% of Sexually Active Teenagers Are Tested for HIV

Health professionals may not be telling their teenaged patients enough about the importance of HIV testing, CDC researchers conclude. Medscape Medical News

J&J will not join Medicines Patent Pool; Company’s pharma head says mechanism could ’cause disaster’

Pharmaceutical company “Johnson & Johnson has rejected calls to offer patent rights on its HIV medicines to generic drug companies through a” Medicines Patent Pool, created to promote low-cost antiretroviral drugs in low-income countries and the development of new drug combinations and formulations, the Financial Times reports.

HIV Testing Rare in Teens (CME/CE)

(MedPage Today) — Only about one in five sexually active high school students has ever been tested for HIV, CDC researchers reported.

"Science" Names HIV Prevention Trial As Breakthrough Of The Year

Science named the HIV Prevention Trials Network (HPTN) 052 study “Breakthrough of the Year.” FHI 360 congratulates our HPTN 052 collaborating partners on this important achievement. This is the second year in a row that Science selected a trial for which FHI 360 provided scientific leadership and operational support…

Immune Response May Render HIV Vaccine Ineffective

Patients’ immune response to adenovirus-based vaccine components may explain the lack of benefit observed in some vaccine trials. Medscape Medical News

HIV Prevention With Positives

This guideline from the New York State Department of Health offers guidance to clinicians on integrating HIV prevention into primary care. Medscape HIV/AIDS

Critical considerations for adenovirus-based HIV vaccine trials

A clinical trial testing a candidate HIV vaccine known as the STEP study was halted in September 2007 after interim analysis indicated that the vaccine did not work. Moreover, subsequent analyses indicated that the vaccine made some individuals more susceptible to HIV, in particular individuals who had pre-existing immune effectors (antibodies) that recognized a component [...]

HIV Vaccine Hits Another Obstacle (CME/CE)

(MedPage Today) — A detailed examination of immune responses to a failed HIV vaccine candidate has turned up another stumbling block on the road to a successful immunization strategy, researchers reported.

Year in Review: HIV Treatment Is Prevention

(MedPage Today) — As part of the Year in Review series, MedPage Today reporters are revisiting major news stories and following up with an analysis of the impact of the original report, as well as subsequent news generated by the initial publication. Here we examine the impact of an international clinical trial that galvanized the [...]